| PACKAGING TYPE: | 10x15 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Vildagliptin (50mg)+metformin (500mg) |
| FORMULATION: | Tablet |
| Description: | VIDASAFE MET 50/500 Tablet is a combination oral antidiabetic medication containing Vildagliptin 50mg and Metformin 500mg. It is used to manage type 2 diabetes mellitus effectively by targeting blood sugar through dual mechanisms: Vildagliptin (DPP-4 inhibitor) – enhances incretin hormones, improving insulin secretion and reducing glucagon levels. Metformin (Biguanide) – decreases hepatic glucose production, improves insulin sensitivity, and reduces intestinal glucose absorption. This combination provides enhanced glycemic control, supporting better management of diabetes with a lower risk of hypoglycemia. |
| Side Effects: | Common side effects: Nausea or vomiting Diarrhea or stomach upset Headache Mild dizziness Serious (rare) side effects: Lactic acidosis (extremely rare but serious) Severe allergic reactions Liver or kidney function abnormalities |
| How to Use: | Take the tablet as prescribed by your doctor Usually administered once or twice daily, preferably with meals to reduce gastrointestinal side effects Swallow whole with water Regular monitoring of blood sugar levels is recommended |
| Precaution: | Use cautiously in patients with kidney or liver impairment Maintain adequate hydration while on Metformin Inform your doctor of all medications and medical conditions Not recommended during pregnancy or breastfeeding unless prescribed Monitor blood sugar, kidney function, and liver function regularly |
| Product Benefits: | Dual-action control of blood sugar levels in type 2 diabetes Enhances insulin secretion and reduces glucagon (Vildagliptin) Lowers hepatic glucose production and improves insulin sensitivity (Metformin) Can be used in patients inadequately controlled o |
Frequently Asked Questions
It is used to manage type 2 diabetes by combining Vildagliptin and Metformin for dual-action blood sugar control.
Vildagliptin improves insulin secretion and reduces glucagon, while Metformin decreases glucose production in the liver and improves insulin sensitivity.
Yes, Metformin may support mild weight loss while aiding glycemic control.












